This trend corroborates the finding of Wanja et al. [10] who, in an evaluation of the diagnostic performance of four types of RDTs targeting HRP2 (2016) in Kenya, noted that the overall sensitivity, which was > 90% for the four RDTs evaluated, fell below 90% for parasitemia < 200 P/μl (sensitivity between 79 and 89%). This evidence concerns the gene HDGFL2 and parasitic infectious disease.